Sulfobromophthalein sodium, hereafter referred to as BSP, has frequently been employed to appraise hepatic function in the newborn infant (1-7). With but one exception (2), many studies have demonstrated delayed disappearance of BSP from blood and increased BSP retention in both the full-term and premature infant in the immediate postpartum period (1, 3-7). Subsequently, the rate of removal of BSP from blood gradually increased, and within a few weeks after birth, approached values found in older children and adults. In general, the impairment of BSP clearance in the first few days after delivery has been attributed to immaturity, and the gradual improvement to maturation of the factors involved in the hepatic removal of BSP from blood and the subsequent excretion of BSP into bile.
Sulfobromophthalein sodium, hereafter referred to as BSP, has frequently been employed to appraise hepatic function in the newborn infant (1) (2) (3) (4) (5) (6) (7) . With but one exception (2) , many studies have demonstrated delayed disappearance of BSP from blood and increased BSP retention in both the full-term and premature infant in the immediate postpartum period (1, (3) (4) (5) (6) (7) . Subsequently, the rate of removal of BSP from blood gradually increased, and within a few weeks after birth, approached values found in older children and adults. In general, the impairment of BSP clearance in the first few days after delivery has been attributed to immaturity, and the gradual improvement to maturation of the factors involved in the hepatic removal of BSP from blood and the subsequent excretion of BSP into bile.
Based on a considerable body of evidence which has been accumulated within the past few years (8) (9) (10) (11) (12) (13) (14) (15) , it is now known that a major fraction of the BSP which is removed from blood and excreted into bile undergoes metabolic transformation within the liver. There appears to be general agreement that the major pathway of BSP metabolism in man, rat, dog, and other species involves conjugation with the tripeptide glutathione in thioether linkage (12) (13) (14) (15) . Recently, we identified an enzyme in the soluble supernatant fraction of liver that catalyzes BSP-glutathione conjugation (15) . During conjugation, whether enzymecatalyzed or not, bromine is released from BSP, and the sulfur group of glutathione attaches to BSP at the site of bromine removal (13, 15) . * This work was supported by research grants from the United States Public Health Service (H-3439), and the American Heart Association. Part of this work has appeared in abstract form (J. clin. Invest. 1961 Invest. , 40, 1030 and was presented at the annual meeting of the American Association for the Study of Liver Diseases, Chicago, Ill., November, 1960. Glutathione appears to be the only necessary substrate for BSP conjugation. No requirement for cofactor has been demonstrated (15) .
The objective of the present study was to determine if the initial delay, then improvement in BSP clearance observed in the neonatal period, might be related to alterations in BSP metabolism. To achieve this, the BSP-glutathione conjugating system was appraised by assaying conjugating enzyme activity and measuring glutathione content of livers obtained from rats at various stages of development.
METHODS
ESP-glutathione conjugating enzyme activity and glutathione content were measured in livers of SpragueDawley rats of various ages. In assigning an age to fetuses in utero, it was assumed that the gestation period of the rat was 21 days from the date of fertilization. The animals were killed by a blow on the head, their throats cut, the livers removed rapidly, chilled, and weighed. Livers obtained from several litter mates of the younger rats were pooled in order to provide enough tissue for duplicate measurements.
1. Incubation procedure. Aliqupts of liver were homogenized with various volumes of ice cold 0.1 M phosphate buffer, pH 7.8, either in a Dounce homogenizer (16) , or in a motor-driven homogenizer utilizing a Teflon pestle.1 The homogenates were then used for assay of BSP-glutathione conjugating enzyme. The homogenates were incubated in a test tube with BSP and glutathione in room air in a constant temperature water bath set at 370 C for 5 minutes. Incubation was terminated by addition of 0.36 ml of saturated ammonium sulfate and 5 ml of absolute ethanol (15) . The contents of the tubes were thoroughly mixed, allowed to stand for 20 minutes at room temperature, then centrifuged at 2,500 rpm for 10 minutes.
2. Chromatography of BSP compounds. The above supernatant fluids were chromatographed in a descending system on Whatman no. 1 filter paper strips. BSP bands were identified by exposing the dried papers to ammonia vapors. In these studies, two bands were identified: one corresponded to BSP-glutathione, the other to 1 Purchased from Kontes Glass Company. (Figure 2 ). Although protein concentration in liver increases after delivery (Table  I) , it does so to a lesser extent than the rise in enzyme activity. Conjugating enzyme activity was also measured in maternal liver obtained at various stages before and after delivery and compared with values obtained in adult nonpregnant female rats ( Figures  3 and 4 The effect of mixing fetal and adult liver homogenates on conjugating enzyme activity was determined in order to detect the possible presence of an enzyme inhibitor in fetal liver or an enzyme activator in adult liver. The resultant enzyme activity of such mixtures was found to be equal to the arithmetic mean of the activities of the original homogenates (Table II) .
2. Liver glutathione. The data are summarized in Figure 5 . Liver glutathione concentration in ti') 2. ,U\ ala 1. The present studies provide no direct explanation for the low conjugating enzyme activity found in fetal liver and the rapid increase in activity observed during the first few days after delivery. Mixing fetal and adult liver homogenates did not result in depression or enhancement of the expected average enzyme activity, tending to exclude the presence of an enzyme inhibitor in fetal liver or an enzyme activator in adult liver. The possibility of substrate induction of the enzyme cannot be resolved with certainty, since the identity of other physiological substrates in addition to glutathione is unknown. It is obvious that the increase in hepatic enzyme activity occurred in the absence of any exposure of the newborn animals to BSP. Although BSP was used to assay enzyme activity in these studies, we have demonstrated that the enzyme is not specific for BSP since it will catalyze the conjugation of glutathione with other compounds (18) . In general, these are predominantly halogenated compounds that have been shown to be excreted as mercapturic acids (19) . Although such compounds are exogenous, an as yet unknown endogenous compound that conjugates with the sulfur group of glutathione may be a physiological substrate for the enzyme. Further speculation about changes in hepatic content of such a hypothetical compound during the neonatal period, however, is unwarranted. It is possible that glutathione acted as a substrate inducer of increased enzyme activity. If so, it is striking that conjugating enzyme changed very little prior to delivery but changed markedly in the first few days post partum, despite a relatively constant concentration of glutathione in this period. Nevertheless, enzyme activity increased to approximately 50 per cent of adult levels, when glutathione concentration was about 50 to 60 per cent of adult values. Thereafter, liver glutathione concentration and BSP-conjugating enzyme activity appeared to increase proportionately until adult values were reached.
Of considerable interest is the observation that conjugating enzyme activity of maternal liver was decreased in the last trimester of pregnancy. Furthermore, after delivery, maternal enzyme activity rapidly increased and within a few days reached and even appeared to overshoot control values. These findings, in addition to the changes observed in fetal enzyme activity, suggest the presence of some inhibitory factor in pregnancy that decreases or disappears at the time of delivery, resulting in depression of conjugating enzyme activity of both the maternal and fetal liver during pregnancy and rapid increase in activity after birth. Recently, Lathe and Walker have presented evidence for the presence of a factor in human pregnancy sera that inhibits conjugation of bilirubin by liver slices (20) . This factor increases during pregnancy, reaching a peak during the last trimester, then decreases after delivery. It is also found in fetal sera, but in lower concentration than in maternal sera, suggesting a maternal origin. After birth, the concentration of this factor in infant sera declines rather rapidly. Various steroids in concentrations approaching the physiological range were also found to inhibit bilirubin conjugation by liver slices (20) , suggesting that the inhibitory substances present in pregnancy sera might be steroid hormones produced in abundance during pregnancy. Although the nature of the inhibitor of bilirubin conjugation is still unknown, one can speculate that such an inhibitor may also be responsible for decreased BSP-conjugating activity of maternal and fetal liver during pregnancy. Our current findings suggest that decreased BSP metabolism followed by a gradual increase may account, at least in part, for the delayed, then improved, BSP clearance from blood observed in the neonatal period by others (1, 3-7) . Implicit in such a suggestion is that conjugation of BSP exerts a significant influence on the rate of BSP uptake by liver cells. It is currently believed that hepatic removal of BSP from plasma depends on the simultaneous operation of at least two separate processes: 1) uptake of BSP in liver cells in an amount proportional to plasma concentration, and 2) active secretion into bile (21) (22) (23) (24) (25) (26) (27) (28) . Conjugation of BSP with glutathione is not obligatory for hepatic BSP uptake, since appreciable quantities of free BSP may be found in the liver within minutes after intravenous administration (29) . In addition, since free BSP has been regularly identified in bile (8) (9) (10) (11) (12) (13) , it is apparent that conjugation of BSP is not a prerequisite for biliary excretion. Nevertheless, once taken up in the liver, a major portion of the BSP is metabolized; over 50 per cent of the BSP recovered in liver 5 to 20 minutes after administration was shown to be conjugated (29) . Furthermore, metabolized BSP accounts for most of the BSP excreted into bile in various species (8) (9) (10) 29) . If conjugated BSP can be stored in liver or transported into bile to a greater extent than free BSP, metabolism of this compound may permit increased hepatic uptake. In preliminary studies we have been unable to demonstrate that conjugation influences the extent to which BSP is stored in the liver (30) . However, observations of Philp, Grodsky and Carbone (29) and in our own laboratory (30) suggest that conjugated BSP can be excreted into bile at a faster rate than free BSP. Alterations in other factors that may affect hepatic uptake of BSP in the neonatal period, such as 1) improved hepatic circulation, 2) development of the transport mechanisms concerned with BSP movement across the hepatic cell membrane at both the sinusoidal and canalicular surfaces, and 3) changes in the quality and quantity of protein in liver cells that may be involved in intrahepatic binding and storage of BSP, were not assessed and were by no means excluded by the present studies.
The present data are probably also relevant to mercapturic acid synthesis in the neonatal period. As mentioned previously, the liver enzyme assayed in the current studies is not specific for BSP because it will also catalyze the conjugation of glutathione with compounds such as benzyl chloride, bromobutane, p-fluoronitrobenzene, and others known to be excreted, at least in part, as mercapturic acids (19) . Since it is likely that conjugation with glutathione is the first step in the formation of mercapturic acids (31, 32) , the findings of low enzyme activity and low glutathione levels in liver suggest that mercapturic acid synthesis will be impaired in the newborn.
SUMMARY AND CONCLUSIONS
The BSP-glutathione conjugating system was examined in livers obtained from rat fetuses, in utero, and at various stages of development after delivery. BSP-glutathione conjugating enzyme activity of fetal liver was very low in the few days before birth, then rapidly increased 2.5-to 10-fold to approximately 50 per cent of adult activity by the third postpartum day. Thereafter it increased gradually, reaching adult levels by 5 to 7 weeks after delivery. Conjugating enzyme activity in maternal liver was also depressed prior to term, then rapidly increased soon after delivery. The concurrent depression of fetal and maternal enzyme activity during the latter part of gestation, followed by a rapid increase in activity in the early postpartum period, suggests the presence of an enzyme inhibitor in pregnancy that disappears after delivery. No evidence was found of an enzyme inhibitor in fetal liver or of enzyme activator in adult liver.
Hepatic glutathione concentration of young rats was reduced to approximately 50 to 60 per cent of adult levels in the few days before and for 3 weeks after delivery. Thereafter it reached adult levels. Glutathione levels of maternal liver obtained before and after term remained within the adult range.
The data suggest that delayed BSP clearance from blood observed in the human premature and full-term infant may be due, at least in part, to inadequate development of the BSP-glutathione conjugating system. Improved BSP clearance with increasing age could be explained by maturation of the conjugating mechanism.
